-
Loading metrics
Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- John C. Morris,
- Antoinette R. Tan,
- Thomas E. Olencki,
- Geoffrey I. Shapiro,
- Bruce J. Dezube,
- Michael Reiss,
- Frank J. Hsu,
- Jay A. Berzofsky,
- Donald P. Lawrence
x
- Published: March 11, 2014
- https://doi.org/10.1371/journal.pone.0090353